Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-cancer effects of JAK2 inhibitors in combination with thalidomide derivatives and glucocorticoids

Anti-cancer effects of JAK2 inhibitors in combination with thalidomide derivatives and glucocorticoids

US Patent 11246876 · Granted Feb 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Diagnostic, prognostic, and monitoring methods for chronic lymphocytic leukemia2024
Methods for monitoring immune status of a subject2023
Diagnostic, prognostic, and monitoring methods for solid tumor cancers2023
Anti-cancer effects of JAK2 inhibitors in combination with thalidomide derivativ2019
Diagnostic, prognostic, and monitoring methods for multiple myeloma, chronic lym2018
Compositions and methods for treatment of drug resistant multiple myeloma2015
Combination therapy for the treatment of multiple myeloma2014